(Q45906659)

17 December 2017

title

Low CADM2 expression predicts high recurrence risk of hepatocellular carcinoma patients after hepatectomy. (English)

1 reference

17 December 2017

1 reference

Sen Yang

1

1 reference

17 December 2017

Hong-Li Yan

2

1 reference

17 December 2017

Qi-Fei Tao

3

1 reference

17 December 2017

Sheng-Xian Yuan

4

1 reference

17 December 2017

Guan-Nan Tang

5

1 reference

17 December 2017

Yuan Yang

6

1 reference

17 December 2017

Li-Li Wang

7

1 reference

17 December 2017

Yi-Liang Zhang

8

1 reference

17 December 2017

Shu-Han Sun

9

1 reference

17 December 2017

Wei-Ping Zhou

10

1 reference

17 December 2017

publication date

17 November 2013

1 reference

17 December 2017

Journal of Cancer Research and Clinical Oncology

published in

1 reference

17 December 2017

volume

140

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

109-116

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1007/s00432-013-1536-8

exact match

0 references

cites work

Hypoexpression and epigenetic regulation of candidate tumor suppressor gene CADM-2 in human prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

Cadm1 is a metastasis susceptibility gene that suppresses metastasis by modifying tumor interaction with the cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

An analysis of 412 cases of hepatocellular carcinoma at a Western center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

Early viral suppression predicts good postoperative survivals in patients with hepatocellular carcinoma with a high baseline HBV-DNA load

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

Combination of peritumoral mast cells and T-regulatory cells predicts prognosis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

AFP-L3: a new generation of tumor marker for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

Prognosis of hepatocellular carcinoma: the BCLC staging classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

Prognostic molecular markers in hepatocellular carcinoma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

Aberrations of a cell adhesion molecule CADM4 in renal clear cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

The cell adhesion nectin-like molecules (Necl) 1 and 4 suppress the growth and tumorigenic ability of colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

Nectins and nectin-like molecules: roles in cell adhesion, migration, and polarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

Surgical treatment for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

Cell adhesion and prostate tumor-suppressor activity of TSLL2/IGSF4C, an immunoglobulin superfamily molecule homologous to TSLC1/IGSF4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1536-8

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

21 January 2018

1 reference

12 December 2020

Risk factors for hepatocellular carcinoma among patients with chronic liver disease

1 reference

12 December 2020

A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients

1 reference

12 December 2020

Involvement of TSLC1 in progression of esophageal squamous cell carcinoma

1 reference

12 December 2020

10.1007/S00432-013-1536-8

Identifiers

DOI

1 reference

17 December 2017

Dimensions Publication ID

1029984343

0 references

Fatcat ID

release_cajbfrh5wvb2pm7657imd762qq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cajbfrh5wvb2pm7657imd762qq

24 November 2022

mapped directly with Wikidata item

1 reference

17 December 2017